About us

Access to >1500 Drug Development Professionals

If you search the internet for drug development services, you will probably find one of our cluster members. For us this is not a surprise, the companies constituting the Drug Development Cluster have been working for the global top-20 pharmaceutical companies for 10-15 years. However, the market has changed, and now many small/virtual biotech companies have discovered the strength of the knowledge base of the cluster. The cluster gives direct access to >500 professionals involved with various aspects of drug development, from discovery up to drug product development.

An Integrated Outsourcing Network

The Drug Development Cluster is a new outsourcing platform that incorporates the best of two worlds: a set of expert services provided by a team of independent companies while maintaining speed, flexibility and optimal project management. End-to-end project visibility through the cluster and across the companies ensures that your project is always kept on track, optimizing the use of time and money…and minimizing risk. Plan for success…quicker to milestone translates to quicker to market ! 

 

News
Cml europe successfully undergoes first regulatory audit for commercial product Cambridge Major Laboratories Europe (CMLE), a leading supplier of chemistry services supporting drug substance development, has successfully completed its first regulatory pre-approval inspection (PAI) for a commercial API. Read more >
Cml selected by summit corp Cambridge Major Laboratories Europe Selected to Support Summit’s “Superbug Antibiotic” Clostridium Difficle Programme Read more >
Events
Bioeurope 2011 dusseldorf Drug Development Cluster will be exhibiting at the autumn edition of BioEurope 2011 Read more >
Knowledge for growth sponsorship Drug Development Cluster sponsors the Knowledge for Growth meeting in Ghent on May 5, 2011 Read more >